696
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Reducing neurotoxicity in the management of multiple myeloma

Pages 2043-2044 | Received 16 Feb 2011, Accepted 29 Jun 2011, Published online: 18 Aug 2011
 

Potential conflict of interest:

The author has received honoraria from Celgene & Millenium pharmacuticals. A disclosure form provided by the author is available with the full text of this article at www.informahealthcare.com/lal

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.